Aviragen Therapeutics (AVIR) Earnings
|
Expand Research on AVIR
| Next EPS Date | 5/8/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +9.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/8/24 | Q124 | N/A | -$0.61 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/28/24 | Q423 | -$0.47 | -$0.43 | -$0.04 | N/A | N/A | N/A |  | | Details | |
| 11/8/23 | Q323 | -$0.40 | -$0.46 | +$0.06 | N/A | N/A | N/A | | | Details | |
| 8/8/23 | Q223 | -$0.34 | -$0.47 | +$0.13 | N/A | N/A | N/A | | | Details | |
| 5/10/23 | Q123 | N/A | -$0.50 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/28/23 | Q422 | -$0.41 | -$0.44 | +$0.03 | N/A | N/A | N/A | | | Details | |
| 11/7/22 | Q322 | -$0.34 | -$0.44 | +$0.10 | $32.81M | N/A | N/A | | | Details | |
| 8/8/22 | Q222 | -$0.38 | -$0.49 | +$0.11 | N/A | N/A | N/A | | | Details |
